BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 28396251)

  • 1. Gene expression profiling of bone marrow mesenchymal stem cells from Osteogenesis Imperfecta patients during osteoblast differentiation.
    Kaneto CM; Pereira Lima PS; Prata KL; Dos Santos JL; de Pina Neto JM; Panepucci RA; Noushmehr H; Covas DT; de Paula FJA; Silva WA
    Eur J Med Genet; 2017 Jun; 60(6):326-334. PubMed ID: 28396251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoblastic differentiation of bone marrow mesenchymal stromal cells in Bruck Syndrome.
    Kaneto CM; Lima PS; Zanette DL; Oliveira TY; de Assis Pereira F; Lorenzi JC; Dos Santos JL; Prata KL; Neto JM; de Paula FJ; Silva WA
    BMC Med Genet; 2016 May; 17(1):38. PubMed ID: 27146342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The osteogenic or adipogenic lineage commitment of human mesenchymal stem cells is determined by protein kinase C delta.
    Lee S; Cho HY; Bui HT; Kang D
    BMC Cell Biol; 2014 Nov; 15():42. PubMed ID: 25420887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential long noncoding RNA/mRNA expression profiling and functional network analysis during osteogenic differentiation of human bone marrow mesenchymal stem cells.
    Zhang W; Dong R; Diao S; Du J; Fan Z; Wang F
    Stem Cell Res Ther; 2017 Feb; 8(1):30. PubMed ID: 28173844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Umbilical cord mesenchymal stem cells: role of regulatory genes in their differentiation to osteoblasts.
    Ciavarella S; Dammacco F; De Matteo M; Loverro G; Silvestris F
    Stem Cells Dev; 2009 Oct; 18(8):1211-20. PubMed ID: 19125623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired osteoblastogenesis in a murine model of dominant osteogenesis imperfecta: a new target for osteogenesis imperfecta pharmacological therapy.
    Gioia R; Panaroni C; Besio R; Palladini G; Merlini G; Giansanti V; Scovassi IA; Villani S; Villa I; Villa A; Vezzoni P; Tenni R; Rossi A; Marini JC; Forlino A
    Stem Cells; 2012 Jul; 30(7):1465-76. PubMed ID: 22511244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone in osteogenic medium strongly induces adipocyte differentiation of mouse bone marrow stromal cells and increases osteoblast differentiation.
    Ghali O; Broux O; Falgayrac G; Haren N; van Leeuwen JP; Penel G; Hardouin P; Chauveau C
    BMC Cell Biol; 2015 Mar; 16():9. PubMed ID: 25887471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of PPAR-γ inhibition on gene expression and the progression of induced osteogenic differentiation of human mesenchymal stem cells.
    Granéli C; Karlsson C; Brisby H; Lindahl A; Thomsen P
    Connect Tissue Res; 2014 Aug; 55(4):262-74. PubMed ID: 24708348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The synergistic effect of NELL1 and adipose-derived stem cells on promoting bone formation in osteogenesis imperfecta treatment.
    Liu Y; Ju M; Wang Z; Li J; Shao C; Fu T; Jing Y; Zhao Y; Lv Z; Li G
    Biomed Pharmacother; 2020 Aug; 128():110235. PubMed ID: 32454289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Participation of TNF-α in Inhibitory Effects of Adipocytes on Osteoblast Differentiation.
    Abuna RP; De Oliveira FS; Santos Tde S; Guerra TR; Rosa AL; Beloti MM
    J Cell Physiol; 2016 Jan; 231(1):204-14. PubMed ID: 26059069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone morphogenetic protein-2 enhances the osteogenic differentiation capacity of mesenchymal stromal cells derived from human bone marrow and umbilical cord.
    Marupanthorn K; Tantrawatpan C; Kheolamai P; Tantikanlayaporn D; Manochantr S
    Int J Mol Med; 2017 Mar; 39(3):654-662. PubMed ID: 28204808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycogen synthase kinase-3α/β inhibition promotes in vivo amplification of endogenous mesenchymal progenitors with osteogenic and adipogenic potential and their differentiation to the osteogenic lineage.
    Gambardella A; Nagaraju CK; O'Shea PJ; Mohanty ST; Kottam L; Pilling J; Sullivan M; Djerbi M; Koopmann W; Croucher PI; Bellantuono I
    J Bone Miner Res; 2011 Apr; 26(4):811-21. PubMed ID: 20939016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bortezomib enhances the osteogenic differentiation capacity of human mesenchymal stromal cells derived from bone marrow and placental tissues.
    Sanvoranart T; Supokawej A; Kheolamai P; U-Pratya Y; Klincumhom N; Manochantr S; Wattanapanitch M; Issaragrisil S
    Biochem Biophys Res Commun; 2014 May; 447(4):580-5. PubMed ID: 24747566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-124 negatively regulates osteogenic differentiation and in vivo bone formation of mesenchymal stem cells.
    Qadir AS; Um S; Lee H; Baek K; Seo BM; Lee G; Kim GS; Woo KM; Ryoo HM; Baek JH
    J Cell Biochem; 2015 May; 116(5):730-42. PubMed ID: 25424317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGFβ-induced switch from adipogenic to osteogenic differentiation of human mesenchymal stem cells: identification of drug targets for prevention of fat cell differentiation.
    van Zoelen EJ; Duarte I; Hendriks JM; van der Woning SP
    Stem Cell Res Ther; 2016 Aug; 7(1):123. PubMed ID: 27562730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinamide phosphoribosyltransferase (Nampt) may serve as the marker for osteoblast differentiation of bone marrow-derived mesenchymal stem cells.
    He X; He J; Shi Y; Pi C; Yang Y; Sun Y; Ma C; Lin L; Zhang L; Li Y; Li Y
    Exp Cell Res; 2017 Mar; 352(1):45-52. PubMed ID: 28159473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Three Early Phases of Cell-Fate Determination during Osteogenic and Adipogenic Differentiation by Transcription Factor Dynamics.
    van de Peppel J; Strini T; Tilburg J; Westerhoff H; van Wijnen AJ; van Leeuwen JP
    Stem Cell Reports; 2017 Apr; 8(4):947-960. PubMed ID: 28344004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells.
    Bäckesjö CM; Li Y; Lindgren U; Haldosén LA
    J Bone Miner Res; 2006 Jul; 21(7):993-1002. PubMed ID: 16813520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms.
    Otsuru S; Gordon PL; Shimono K; Jethva R; Marino R; Phillips CL; Hofmann TJ; Veronesi E; Dominici M; Iwamoto M; Horwitz EM
    Blood; 2012 Aug; 120(9):1933-41. PubMed ID: 22829629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA expression profiling of human bone marrow mesenchymal stem cells during osteogenic differentiation reveals Osterix regulation by miR-31.
    Baglìo SR; Devescovi V; Granchi D; Baldini N
    Gene; 2013 Sep; 527(1):321-31. PubMed ID: 23827457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.